News Highlights: Top M &A Stories Of The Day

HD
WC
PD
ET
SN
SC
LA
CY
LP

TD

News Highlights: Top M&A Stories Of The Day

297 words
22 April 2014
23:05
Dow Jones Institutional News
DJDN
English
Copyright © 2014, Dow Jones & Company, Inc.

Valeant, Ackman Propose Allergan Deal
Activist investor William Ackman and Valeant Pharmaceuticals revealed their offer to acquire the wrinkle
treatment maker Allergan. The deal values Allergan at about $152.89 a share, or a total of $45.6 billion.
Allergan shares rose 20% premarket.

Novartis In Deals Worth $25 Billion
Novartis said it will acquire the oncology unit of GlaxoSmithKline for about $14.5 billion and sell its
vaccines unit to GSK for $5.25 billion. Novartis also said it is selling its animal health unit to Eli Lilly &
Co. for around $5.4 billion.
Healthscope Draws Interest from China, Malaysia and U.S.
Australia's Healthscope, a hospital and pathology company put on the block by its private-equity
owners TPG Capital and Carlyle Group, has attracted interest from the U.S., China and Malaysia,
people with knowledge of the deal said.

Ackman, Valeant to Pursue Allergan Takeover
William Ackman and Valeant Pharmaceuticals are said to be teaming up to try to buy wrinkle-treatment
Botox maker Allergan in an unorthodox alliance between an activist investor and corporate acquirer.

Goldcorp Drops Pursuit of
Osisko Mining
Goldcorp said it won't boost its offer for Osisko Mining Corp., paving the way for rival miners Yamana
Gold Inc. and Agnico-Eagle Mines Ltd. to close their friendly takeover of the Quebec-based miner.

QinetiQ to Sell US Services Division for Initial $165M in Cash
QinetiQ Group PLC Tuesday announced the disposal of its U.S. Services division for a total
consideration of $215 million, and said it will return 150 million pounds ($251.99 million) to
shareholders by way of a share buyback program.

(END) Dow Jones Newswires

April 22, 2014 09:05 ET (13:05 GMT)

CO

IN

trimel : Valeant Pharmaceuticals International Inc. | allgop : Allergan Inc | glxo : GlaxoSmithKline PLC |
goldi : Goldcorp Inc | sndoz : Novartis AG
i22472 : Precious Metals | i257 : Pharmaceuticals | i364 : Aerospace Products/Parts | i951 : Health
Care/Life Sciences | iindstrls : Industrial Goods | i22 : Primary Metals | i224 : Non-ferrous Metals | iaer :

Page43of283©2018Factiva,Inc.Allrightsreserved.Aerospace/Defense | ibasicm : Basic Materials/Resources | i211 : Metal Ore Mining | imet :
Mining/Quarrying | igoldm : Gold Ore Mining
c181 : Acquisitions/Mergers/Takeovers | ccat : Corporate/Industrial News | mgabon : Government
Agency Securities | ncdig : Corporate Digests | ncmac : Commodities Asset Class News | neqac :
Equities Asset Class News | nfiac : Fixed Income Asset Class News | nhhour : Headlines of the Hour |
cacqu : Acquisitions | c18 : Ownership Changes | cactio : Corporate Actions | m12 : Debt/Bond Markets |
mcat : Commodity/Financial Market News | mgvdbt : Government Debt/Bond Markets | ncat : Content
Types | ndj : Dow Jones Top Stories | nfact : Factiva Filters | nfce : FC&E Exclusion Filter | nfcpin :
FC&E Industry News Filter | ntop : Top Wire News | redit : Selection of Top Stories/Trends/Analysis
austr : Australia | cana : Canada | caon : Ontario | eurz : Europe | uk : United Kingdom | usa : United
States | usin : Indiana | apacz : Asia Pacific | ausnz : Australia/Oceania | eecz : European Union
Countries | namz : North America | usc : Midwest U.S. | weurz : Western Europe
Dow Jones & Company, Inc.
Document DJDN000020140422ea4m001ts

NS

RE

PUB
AN

Page44of283©2018Factiva,Inc.Allrightsreserved.